Market News (Page 109) - TendieTensor

Market News Page 109 of 158 • 3,948 articles

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

Benzinga • Prnewswire

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

11/03/2025 08:30 AM • SuperCom, a global provider of secured solutions for e-Government, IoT, and Cybersecurity, will hold a conference call on November 13, 2025, to discuss its third quarter 2025 financial results.

SPCB - The article is a standard financial results announcement without indicating positive or negative performance, presenting a neutral informative tone about the upcoming earnings call

#financial results #conference call #e-Government #IoT #Cybersecurity

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

Benzinga • Prnewswire

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

11/03/2025 08:30 AM • TOYO Co., Ltd has entered a strategic partnership with Voltec Solar, a French photovoltaic panel manufacturer, to supply high-performance, low-carbon solar cells in the European market, marking TOYO's expansion into Europe.

TOYO - Company is expanding into European market, establishing a strategic partnership, and demonstrating commitment to global solar technology innovation

#solar solutions #strategic partnership #low-carbon technology #European market #sustainability

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

The Motley Fool • Rachel Warren

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

11/03/2025 08:28 AM • The article highlights two healthcare stocks suitable for long-term investors: Eli Lilly and Intuitive Surgical. Both companies demonstrate strong growth potential, innovative product pipelines, and consistent financial performance in the healthcare sector.

LLY - Strong revenue growth (38% YoY), successful GLP-1 franchise, promising drug pipeline in oncology and neuroscience, consistent dividend history, and strategic manufacturing investments

#healthcare #long-term investing #pharmaceutical #surgical robotics #GLP-1 #medical technology

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

Benzinga • Namrata Sen

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

11/03/2025 08:27 AM • Morgan Stanley analysts warn of two key risks for US stocks: the Federal Reserve's cautious interest rate policy and potential tariff impacts. Despite strong corporate earnings, market uncertainty remains about future monetary stance.

QQQ - Year-to-date performance is strong (+23.29%), but analysts caution about potential market challenges

#Federal Reserve #interest rates #stock market #corporate earnings #tariffs

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Benzinga • Prnewswire

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

11/03/2025 08:25 AM • NewcelX, a Swiss clinical-stage biopharmaceutical company, announced a strategic roadmap update after merging with NLS Pharmaceutics Ltd., focusing on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

NCEL - Company provided a strategic update and investor presentation, indicating ongoing development of therapeutic platforms without explicitly positive or negative financial indicators

#biotechnology #neurodegenerative diseases #metabolic diseases #clinical trials #stem-cell technologies

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

Benzinga • Rishabh Mishra

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

11/03/2025 08:22 AM • U.S. stock futures advanced on Monday following strong October gains, with markets anticipating potential Federal Reserve interest rate cuts and focusing on upcoming earnings reports from several key companies.

MU - Jumped 4.32% in premarket, supported by upbeat memory chip forecast and maintained strong price trends across short, medium, and long terms

#stock market #futures #earnings #Federal Reserve #interest rates

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

The Motley Fool • Matt Frankel

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

11/03/2025 08:11 AM • PayPal announced its first dividend and highlighted strong AI partnerships with Google and OpenAI, demonstrating potential growth in the fintech and AI sectors with impressive Q3 financial results.

PYPL - Strong Q3 financial performance, new dividend program, strategic AI partnerships, low valuation, and potential for future earnings growth

#PayPal #AI #dividend #fintech #OpenAI #Google

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

The Motley Fool • Matt Frankel

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

11/03/2025 08:08 AM • The article discusses two AI-focused ETFs that offer different investment strategies: the Invesco QQQ ETF, which provides broad AI exposure through large-cap tech stocks, and the Ark Autonomous Technology & Robotics ETF, which focuses on unique AI and robotics opportunities with an actively managed approach.

QQQ - Low expense ratio (0.20%), broad exposure to top AI companies, represents over 56% of assets in top 10 holdings

#AI #ETF #technology #investing #robotics

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

The Motley Fool • Rick Munarriz

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

11/03/2025 08:07 AM • Apple's stock has risen 64% since April, but the company's revenue growth remains slow, with concerns about innovation and sustained growth potential despite hitting new intraday highs.

AAPL - Slow revenue growth (1.8% CAGR over three years), lack of innovation, trading at 33x forward earnings with minimal growth prospects, and potential stagnation after potential short-term growth

#Apple #stock performance #revenue growth #innovation #iPhone #tech stocks

Zscaler Secures The Enterprise AI Lifecycle With Acquisition of Innovative AI Security Pioneer SPLX

Benzinga • Globe Newswire

Zscaler Secures The Enterprise AI Lifecycle With Acquisition of Innovative AI Security Pioneer SPLX

11/03/2025 08:05 AM • Zscaler has acquired AI security company SPLX to enhance its Zero Trust Exchange platform, enabling comprehensive AI lifecycle security with capabilities like AI asset discovery, automated red teaming, and governance.

ZS - Expanding AI security capabilities through strategic acquisition, strengthening market leadership in cloud security

#AI security #zero trust #enterprise security #acquisition #technology

Should You Buy Meta Stock While It's Under $700?

The Motley Fool • Lyle Daly

Should You Buy Meta Stock While It's Under $700?

11/03/2025 08:05 AM • Meta Platforms reported strong Q3 earnings with 26% revenue growth and increased ad performance, but stock dropped due to significant AI infrastructure investments, which investors view with caution.

GEV - Mentioned as a top holding for Thames Capital, but no specific performance details provided
META - Strong ad revenue and AI-driven improvements offset concerns about high capital expenditures on AI infrastructure, resulting in a balanced outlook

#Meta #AI #stock #earnings #advertising #technology

Insurance Arm Steers Loews To Higher Profit With Fewer Catastrophe Losses

Benzinga • Lekha Gupta

Insurance Arm Steers Loews To Higher Profit With Fewer Catastrophe Losses

11/03/2025 08:02 AM • Loews Corporation reported higher Q3 2025 net income of $504 million, driven by strong performance from its insurance arm CNA Financial and improved results across its business segments.

L - Increased net income from $401M to $504M, book value growth, and share repurchases indicate strong financial health

#earnings #insurance #financial performance #stock repurchase

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

Benzinga • Globe Newswire

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

11/03/2025 08:01 AM • MiddleGround Capital has entered into a definitive agreement to sell its portfolio company Lindsay Precast to TJC, LP. Lindsay Precast is a leading manufacturer of prefabricated concrete and steel products serving infrastructure needs across various sectors in the United States.

HALO - Mentioned as provider of ENHANZE drug delivery technology used in VYVGART Hytrulo, with no specific performance details discussed
LNN - Expanded capabilities, made strategic acquisitions, and positioned for future growth under new ownership

#private equity #infrastructure #precast concrete #mergers and acquisitions

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

GlobeNewswire Inc. • Milestone Pharmaceuticals

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

11/03/2025 08:00 AM • Milestone Pharmaceuticals presented clinical trial data for etripamil nasal spray, showing consistent efficacy and safety in treating paroxysmal supraventricular tachycardia (PSVT) across multiple studies, with a New Drug Application currently under FDA review.

PFE - Demonstrated strong innovation with COVID-19 vaccine and antiviral treatment, maintaining leadership in vaccines and infectious disease research
MIST - Presented promising clinical trial results demonstrating consistent efficacy and safety of their lead investigational product, with a pending FDA New Drug Application and potential for a new treatment option in cardiovascular medicine

#etripamil #PSVT #nasal spray #clinical trials #FDA #cardiovascular

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

GlobeNewswire Inc. • Brittany Kaiser

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

11/03/2025 08:00 AM • AlphaTON Capital has partnered with PagoPay and ALT5 Sigma to launch a Mastercard payment card program enabling native cryptocurrency spending, specifically for TON tokens, with seamless digital wallet integration and global merchant acceptance.

ATON - Company is expanding its ecosystem strategy, gaining exclusive rights to market cryptocurrency cards, and creating potential new revenue streams

#cryptocurrency #Mastercard #TON #digital wallet #blockchain #payment card

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

GlobeNewswire Inc. • Sutro Biopharma

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

11/03/2025 08:00 AM • Sutro Biopharma will present preclinical data on advanced antibody-drug conjugates (ADCs) at the 16th Annual World ADC Conference, highlighting innovations in dual-payload ADCs and cell-free manufacturing platforms to potentially improve cancer treatment.

COVTY - Listed among competitive market players without specific performance details
STRO - Company is showcasing innovative research, presenting multiple presentations demonstrating technological advancements in ADC development, and emphasizing potential breakthroughs in cancer therapy

#ADCs #oncology #antibody drug conjugates #cancer treatment #preclinical research

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

GlobeNewswire Inc. • Sintx Technologies

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

11/03/2025 08:00 AM • SINTX Technologies launched OsseoSculpt™, a next-generation biologic designed to complement its SINAPTIC® Foot & Ankle Osteotomy Wedge System. The company recorded its first commercial revenue in Q3 2025 and plans a broader U.S. rollout through Q4 2025–Q1 2026.

DDw - Recognized as a significant player in developing advanced plastic compounds with potential for innovation
SINT - Company launched a new product, recorded initial commercial revenue, and has a strategic rollout plan for expanding market presence in the medical device sector

#OsseoSculpt #SINAPTIC #biologic #foot and ankle #osteotomy #medical device

Aeries Technology highlights AI-driven execution to accelerate enterprise transformation

GlobeNewswire Inc. • Unni Nambiar

Aeries Technology highlights AI-driven execution to accelerate enterprise transformation

11/03/2025 08:00 AM • Aeries Technology showcased its expanded AI-enabled implementation projects that improve productivity and operational efficiency across various business functions through consulting-led execution and deep functional specialization.

DD - Recognized as a significant player in developing advanced plastic compounds with potential for innovation
AERT - The company demonstrated strong capabilities in AI-powered business transformation, highlighting successful implementation projects that increased productivity, reduced operational time, and improved compliance across multiple business functions

#AI #business transformation #Global Capability Center #digital transformation #implementation

Avalyn to Participate in Multiple Upcoming Investor Conferences in November

GlobeNewswire Inc. • Globe Newswire

Avalyn to Participate in Multiple Upcoming Investor Conferences in November

11/03/2025 08:00 AM • Avalyn Pharma, a clinical-stage biopharmaceutical company, will participate in multiple healthcare investor conferences in November 2025, presenting its innovative inhaled therapies for pulmonary fibrosis treatment.

DOW - Highlighted as a major competitor with strong market presence in plastic compounding technologies
JEF - Mentioned as conference host with no specific positive or negative implications

#pulmonary fibrosis #inhaled therapies #clinical-stage #investor conferences

Recludix Pharma to Present at Two Investor Conferences in November

GlobeNewswire Inc. • Matt Caldemeyer

Recludix Pharma to Present at Two Investor Conferences in November

11/03/2025 08:00 AM • Recludix Pharma will present at two healthcare investor conferences in November 2025, highlighting their drug discovery platform focused on developing inhibitors for inflammatory diseases, with a strategic collaboration with Sanofi and plans to submit an Investigational New Drug application for STAT6 inhibitor REX-8756.

SNY - Mentioned in a strategic collaboration with Recludix for STAT6 inhibitor development, with no additional context provided

#drug discovery #inflammatory diseases #STAT6 inhibitor #investor conferences

Organoids Market to Reach USD 381.7 Million by 2034, Expanding at a Robust 18.5% CAGR | Reports Towards Healthcare

GlobeNewswire Inc. • Towards Healthcare

Organoids Market to Reach USD 381.7 Million by 2034, Expanding at a Robust 18.5% CAGR | Reports Towards Healthcare

11/03/2025 08:00 AM • The global organoids market is projected to grow from USD 82.80 million in 2025 to USD 381.7 million by 2034, expanding at an 18.5% CAGR. North America dominates the market, with key growth drivers including advancements in stem cell technology, drug discovery, and precision medicine research.

MRK - Collaborated with Promega Corporation to co-develop novel technologies for drug screening and discovery, leveraging strengths in organoids and synthetic chemistry

#organoids #stem cells #drug discovery #precision medicine #biotechnology

Spectral Capital Corporation to Exceed 300 Patent Filings in Artificial Intelligence and Quantum Computing Toward 500 Patent Goal for 2025

Benzinga • Prnewswire

Spectral Capital Corporation to Exceed 300 Patent Filings in Artificial Intelligence and Quantum Computing Toward 500 Patent Goal for 2025

11/03/2025 07:47 AM • Spectral Capital Corporation announced it will reach its goal of filing 500 patent applications by end of 2025, focusing on artificial intelligence, quantum computing, and hybrid AI-quantum architectures. The company has already crossed 300 patent filings and aims to have 1,000 patents by end of 2026.

MRK - Expanding access to therapies and showing leadership in immunotherapy and vaccine innovations
FCCN - The company is demonstrating significant technological innovation, rapid intellectual property development, and a clear strategic vision for future computing technologies, as evidenced by their ambitious patent filing goals and leadership statements

#artificial intelligence #quantum computing #patent filing #hybrid AI-quantum architectures

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

Benzinga • Stjepan Kalinic

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

11/03/2025 07:39 AM • Coeur Mining announced an all-stock acquisition of New Gold for $7 billion, creating a $20 billion North American precious metals producer with seven mines across the U.S., Canada, and Mexico.

JNJ - Maintaining diverse portfolio across pharmaceuticals, medical devices, and consumer health with steady new therapy developments
CDE - Company will own 62% of combined entity, expects $3 billion EBITDA and $2 billion free cash flow by 2026, creating a larger-scale mining powerhouse

#merger #mining #precious metals #gold #silver #acquisition

Dollar Returns, Central Banks Signal Caution, Capital Seeks Safety

Benzinga • Finit Benzinga Contributor

Dollar Returns, Central Banks Signal Caution, Capital Seeks Safety

11/03/2025 07:36 AM • Central banks like BOJ and Federal Reserve showed cautious monetary policy, causing market uncertainty. Corporate earnings remained strong, with tech companies delivering solid results, but institutional investors are moderating risk exposure.

AMZN - 9.6% stock rally on strong cloud growth and late-session institutional inflows

#monetary policy #central banks #dollar #earnings #market uncertainty

Verde Closes $2 Million Strategic Investment from Commercial Partner Ergon

Benzinga • Prnewswire

Verde Closes $2 Million Strategic Investment from Commercial Partner Ergon

11/03/2025 07:32 AM • Verde Resources secured a $2 million strategic investment from Ergon Asphalt & Emulsions, following a 10-year exclusive licensing agreement for their BioAsphalt™ technology across North America. The investment validates Verde's innovative carbon-sequestering road materials technology.

VRDR - Received significant strategic investment, secured long-term licensing agreement, validated technology performance, and gained a major industry partner

#BioAsphalt #carbon sequestration #sustainable infrastructure #road materials #investment